TrialThe oncologist2020

Phase II Trial of Neoadjuvant Bevacizumab with Modified FOLFOX7 in Patients with Stage II and III Rectal Cancer.

Afsaneh Barzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.